LAKE FOREST, Ill., Aug. 27, 2015 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), the world's leading provider of injectable drugs and
infusion technologies, today announced the first installation of
the Plum 360™ infusion system with Hospira MedNet™, at Shannon
Medical Center in San Angelo,
Texas. The Plum 360 infusion system, supported by the new
Hospira MedNet version 6.1 safety software, is the latest addition
to Hospira's innovative portfolio of next-generation smart
pumps.
"Hospira is excited to partner with Shannon Medical Center on
the launch of the new Plum general infusion device," said
Cynthia Ansari, vice president, U.S.
Marketing and Software, Medical Devices, Hospira. "This marks
another important step on Hospira's journey towards offering the
newest, most advanced line of infusion devices available. Designed
with close attention to the clinical needs of our customers, the
Plum 360 infusion system delivers advanced capabilities to enable
clinical excellence, including automatic default into an enhanced
Hospira MedNet drug library."
Hospira is a leading provider of safety-focused medication
management systems. The Plum 360 infusion system includes unique
features designed to address challenges that hospitals face daily
as they work to improve the safety of intravenous (I.V.) medication
administration. These include a secondary line that connects
directly to the PlumSet™ cassette, enabling the pump to be
programmed with two compatible medications in either concurrent or
piggyback delivery. The secondary line, delivered through channel B
of the pump, also integrates with the electronic medical record
(EMR) systems through Hospira's I.V.-EMR interoperability solution.
The secondary line enables air management that does not require
disconnecting the line from the patient, which helps reduce the
potential for contamination.
Video - Learn more about the unique design and features of
the Plum 360 infusion system here:
http://bit.ly/Plum360
Hospira MedNet further enhances the safety features of the Plum
360 infusion system with an expanded drug library to support safety
limits for more medications, across more clinical care areas of
use, helping to enhance clinical best practices for I.V. medication
administration. The Plum 360 infusion system also provides several
security enhancements, including improved protection of critical
communication ports, no remote command execution, and support for
128-bit SSL encryption of all data transmitted to and from Hospira
MedNet version 6.1.
"Shannon Medical Center is proud to be the first hospital in
the United States to implement
Plum 360 smart infusion pumps," said Becky
Fuentes, R.N., associate chief nursing officer, Shannon
Medical Center. "The adoption of this advanced technology for
intravenous medication administration is another example of
Shannon's commitment to providing
the highest possible quality of care for our patients. The use of
these advanced devices and software will strengthen our efforts to
improve patient safety and support our dedicated caregivers in
their mission to change lives for the better."
Hospira MedNet version 6.1 advances smart pump interoperability
with a new, configurable capability, Alarm Forwarding, that
forwards I.V. device alarm data to EMR and Alarm Management
Systems.* In addition to existing integrated features, including
automated programming of an infusion pump and auto-documentation of
I.V. data to the electronic medical record, Alarm Forwarding can
help to augment a hospital's alarm management policies by
automating the notification of pump alarms to clinicians. Hospira
has implemented I.V.-EMR interoperability at more hospitals than
all other pump vendors combined, and with more major EMR platforms
than any other company.1
The Plum 360 infusion system with Hospira MedNet is a
complementary addition to Hospira's medication management
portfolio, which also includes the new Sapphire™ ambulatory
infusion system and the market-leading LifeCare PCA™ pain
management pump with Hospira MedNet.
About Hospira
Hospira, Inc. is the world's leading provider of injectable
drugs and infusion technologies, and a global leader in
biosimilars. Through its broad, integrated
portfolio, Hospira is uniquely positioned to Advance
Wellness™ by improving patient and caregiver safety while reducing
healthcare costs. The company is headquartered in Lake Forest,
Ill. Learn more at www.hospira.com.
About Shannon Medical Center
Licensed for 400 beds, Shannon Medical Center has served
West Texas for more than 80 years.
The designated lead level 3 trauma center for the region,
Shannon has a nationally
recognized intensive care unit, provides critical care to newborns
as young as 28 weeks gestation, and offers a state-of-the-art
radiology department among many more services. Learn more at
www.shannonhealth.com.
-- Private Securities Litigation Reform Act of 1995 --
A Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Forward-looking
statements generally relate to future events or Hospira's future
financial or operating performance. In some cases, you can identify
forward-looking statements because they contain words such as
"may," "will," "should," "expects," "plans," "anticipates,"
"could," "intends," "target," "projects," "contemplates,"
"believes," "estimates," "predicts," "potential" or "continue" or
the negative of these words or other similar terms or expressions
that concern Hospira's expectations, strategy, plans or intentions.
Forward-looking statements in this press release include Hospira's
expectations regarding regulatory approvals, clinical trials and
the actions of competitors. Hospira's expectations and beliefs
regarding these matters may not materialize, and actual results in
future periods are subject to risks and uncertainties that could
cause actual results to differ materially from those projected.
Actual results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, including, without limitation, challenges inherent in
creating and developing compounds and product candidates and
economic, competitive, governmental, regulatory, legal, supply and
other factors. Information on these and additional risks affecting
Hospira's business and operating results are more fully discussed
in the section entitled "Risk Factors" in Hospira's most recently
filed annual report on Form 10-K and any subsequently filed
quarterly report on Form 10-Q. The forward-looking statements in
this press release are based on information available as of the
date hereof, and Hospira disclaims any obligation to update any
forward-looking statements, except as required by law.
*Requires I.V./EMR interoperability
1. Hess P. Smart pump/EMR integration: What are my
best options? May 2015 Performance
Report. ©2015. KLAS Enterprises, LLC. All rights reserved.
www.KLASresearch.com.
Video - http://youtu.be/0wQrvx-kvro
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hospira-announces-first-installation-of-plum-360-infusion-system-with-hospira-mednet-300133914.html
SOURCE Hospira, Inc.